Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
BEAM
Stock Latest News
Market News
Cathie Wood Dumps Over $5M in a Biotech Stock, Buys WeRide and Tempus AI
4d ago
U
KDK
Premium
Ratings
Beam Therapeutics: Buy Rating Backed by BEAM-302 Progress, 2026 Data Catalyst, and De-Risked Accelerated Approval Path
4d ago
BEAM
Premium
Market News
Cathie Wood Buys Netflix and AI Stocks, Dumps Beam, PINS, and GitLab Shares
5d ago
TEM
WRD
Premium
Ratings
Beam Therapeutics: Undervalued Base-Editing Leader with De-Risked BEAM-302 Driving $46 Price Target and Overweight/Buy Rating
6d ago
BEAM
Premium
The Fly
Beam Therapeutics price target raised to $41 from $37 at Bernstein
7d ago
BEAM
Premium
Ratings
Beam Therapeutics: De-Risked Late-Stage Pipeline, Clear FDA Pathways, and Strong Cash Runway Underscore Buy Rating and $80 Target
13d ago
BEAM
Premium
The Fly
Beam Therapeutics rises 27.9%
15d ago
BEAM
Premium
The Fly
Beam FDA alignment could accelerate review, says William Blair
15d ago
BEAM
Premium
The Fly
Beam Therapeutics higher after reaching FDA alignment on BEAM-302
15d ago
BEAM
Premium
The Fly
Beam Therapeutics rises 23.4%
15d ago
BEAM
Premium
Company Announcements
Beam Therapeutics outlines 2026 strategy and extends runway
15d ago
8K
BEAM
Premium
The Fly
Beam Therapeutics initiated with a Neutral at UBS
20d ago
BEAM
Premium
The Fly
Beam Therapeutics price target raised to $45 from $43 at BofA
21d ago
BEAM
Premium
Market News
Cathie Wood Wraps Up 2025 with New Biotech Buys — Here’s What It Sold
26d ago
BEAM
Premium
Market News
Cathie Wood Closes Out 2025 with a Rocket Lab (RKLB) Trim and Fresh Biotech Bets
27d ago
BEAM
IONS
Premium
Company Announcements
Beam Therapeutics Gains $255M from Orbital Acquisition
2M ago
8K
BEAM
Premium
Ratings
Beam Therapeutics’ Promising BEACON Trial and Advanced Manufacturing Boost Buy Rating
2M ago
BEAM
Premium
Ratings
Promising Clinical Data and Market Potential Drive Buy Rating for Beam Therapeutics’ Sickle Cell Treatment
2M ago
BEAM
Premium
Ratings
Beam Therapeutics: Promising BEACON Trial Results Support Buy Rating
2M ago
BEAM
Premium
The Fly
Beam reports updated data from BEACON Phase 1/2 trial of ristoglogene
2M ago
BEAM
Premium
The Fly
Beam Therapeutics rises 11.3%
2M ago
BEAM
Premium
Market News
3 Penny Stocks to Watch Now, 12/2/25
2M ago
ADTX
BEAM
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
